Bank of New York Mellon Corp - BIOMARIN PHARMACEUTICAL INC ownership

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q3 2020$802,000
-24.1%
800,0000.0%0.00%
Q2 2020$1,057,000800,0000.00%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q4 2020
NameSharesValueWeighting ↓
Sonora Investment Management, LLC 6,195,000$9,377,0002.84%
GUARDIAN LIFE INSURANCE CO OF AMERICA 8,000,000$10,750,0001.09%
Man Investments (CH) AG 1,100,000$1,482,0000.73%
ADVENT CAPITAL MANAGEMENT /DE/ 22,554,000$30,444,0000.47%
SSI INVESTMENT MANAGEMENT LLC 3,124,000$4,202,0000.45%
ARROWGRASS CAPITAL PARTNERS (US) LP 20,000$22,373,0000.42%
Calamos Advisors LLC 35,219,000$47,628,0000.33%
LINDEN ADVISORS LP 2,500,000$3,370,0000.23%
Calamos Wealth Management LLC 513,000$694,0000.17%
LOOMIS SAYLES & CO L P 477,810$50,323,0000.15%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders